Chapter 4 - the doctor who signed after his death
Adrian Keller had been real.
That made everything worse.
He had been a respected immunology researcher in Boston.
Published papers.
Medical lectures.
Hospital appointments.
Then a private-plane crash killed him six years earlier.
No survivors.
Yet someone had used Keller’s identity to contact Mark.
Send instructions.
Transfer money.
Access Sophie’s newborn medical data.
Detective Ortiz brought in Special Agent Daniel Price from the federal health-care fraud unit.
“This is no longer just a child-endangerment investigation,” Price explained.
Hannah sat beside her attorney, Melissa Grant.
“Then what is it?”
“We don’t know yet.”
Price showed them a Northbridge corporate document.
The company had operated observational studies involving children born to mothers who participated in several maternal-health research programs.
Hannah’s name appeared.
H-04.
“What does the H mean?”
“Unknown.”
“Was I part of a trial?”
“You signed a general research consent during pregnancy.”
“I remember donating blood.”
“Northbridge appears to have retained more data than you were told.”
Hannah felt violated.
“What about Sophie?”
“She appears in archived databases as S-17.”
“Meaning?”
“Seventeenth child in one subgroup.”
Melissa asked:
“Was there authorization to enroll children after birth?”
Price shook his head.
“We haven’t found valid consent.”
Mark had been released temporarily under strict conditions while the criminal investigation continued.
He could not contact Sophie.
He could not enter the family home.
He surrendered his passport.
Hannah filed for emergency sole custody.
Mark did not contest it.
That frightened Hannah almost as much as if he had fought.
He knew how bad this looked.
The brown bottle was analyzed.
The substance was not an approved home diagnostic product.
It was a concentrated compound capable of producing predictable irritation in sensitive skin.
Price carefully avoided unnecessary technical detail.
“The important point is that it could create the appearance of a stronger reaction.”
Hannah stared.
“Create?”
“Yes.”
Not detect.
Create.
Mark had not simply been checking whether Sophie reacted.
The sessions might have been provoking the very symptoms Keller wanted documented.
Hannah covered her mouth.
“Why?”
Price opened Northbridge’s old study summary.
Researchers had once investigated an uncommon inflammatory response associated with a particular genetic pattern.
Children who developed the documented response before age six were placed into a high-risk monitoring category.
That category came with long-term research funding.
Melissa frowned.
“How much funding?”
“For the institution? Substantial.”
“Enough to commit fraud?”
Price did not speculate.
Then another record appeared.
Sophie’s code.
S-17.
Beside it:
STATUS: NEGATIVE / INCONCLUSIVE.
A later entry had been added only four months earlier.
REACTIVATION AUTHORIZED.
Hannah felt cold.
“By whom?”
The author field said:
A. KELLER.
A dead man.
Someone was reopening old Northbridge cases under Keller’s credentials.
And attempting to turn negative children into positive ones.
Price had identified seven other families receiving similar monthly payments.
Hannah stared.
“Seven children?”
“Possibly more.”
“Are they being exposed too?”
“We’re contacting them.”
The first family denied everything.
The second father hung up.
The third mother began crying before investigators finished explaining why they were calling.
Her nine-year-old son had undergone “home challenge sessions” for nearly a year.
Different product.
Same timer.
Same secrecy instruction.
Same payments.
Same supposed Dr. Keller.
This was not Mark acting alone.
But Mark had still chosen to participate.
Price said:
“We need to determine what the person using Keller’s identity gains from positive cases.”
Melissa looked at the funding records.
“Follow the money.”
They did.
Northbridge’s old research insurance policy included a special compensation reserve.
If children in the cohort developed certain validated complications, families could receive funded lifetime monitoring while approved research administrators gained access to a large pool reserved for continued study.
Estimated reserve:
$48 million.
Hannah stared.
“So somebody is making children appear sick to unlock the money?”
“Possibly.”
But Price found a problem.
The reserve could not be activated simply by documenting symptoms.
It required independent genetic verification.
Sophie’s file contained no qualifying result.
Yet whoever was directing Mark seemed certain she could produce one.
Then the laboratory received the archived newborn sample from Sophie’s birth hospital.
Price called Hannah immediately.
“You need to come in.”
“What happened?”
“The sample labeled S-17 does contain the genetic marker.”
Hannah stopped.
“But you said her old file was negative.”
“It was.”
“What changed?”
“That’s what we’re investigating.”
Hannah arrived with Melissa.
Price placed two reports on the table.
Sophie’s newborn test from five years earlier:
NEGATIVE.
The newly analyzed stored sample:
POSITIVE.
Both supposedly came from the same infant.
“That’s impossible,” Hannah said.
“Unless one record is wrong.”
“Or the sample isn’t Sophie’s.”
Price nodded.
Then he showed her the chain-of-custody log.
The sample had been removed from storage once.
Three months after Sophie’s birth.
Authorized by:
DR. ADRIAN KELLER.
Hannah stared at the date.
May you like
Keller had already been dead for nearly a year.
👉 Someone had accessed Sophie’s newborn sample under a dead doctor’s name years before Mark ever began the secret bathroom sessions—suggesting the fraud had been prepared almost from birth.
